Literature DB >> 20835270

Pentoxifylline alleviates high-fat diet-induced non-alcoholic steatohepatitis and early atherosclerosis in rats by inhibiting AGE and RAGE expression.

Jing Wu1, Miao-yun Zhao, Hao Zheng, Hua Zhang, Ying Jiang.   

Abstract

AIM: To investigate the expression of advanced glycation end products (AGEs) and their receptor RAGE in the livers and blood vessels of rats with non-alcoholic steatohepatitis (NASH) and the effect of pentoxifylline (PTX) on liver and artery function in rats with NASH.
METHODS: Sprague-Dawley rats were fed a high-fat diet for 12 weeks and given PTX by gavage for 4 weeks. The effects of PTX on hepatic liver and vessel function as well as the expression of AGE and RAGE in rats with NASH were assessed. The intima-media thickness (IMT) of the aorta and carotid artery was evaluated using ultrasonography.
RESULTS: Serum aspartic aminotransferase (AST) and blood levels of glucose (GLU) were reduced in the PTX group relative to the NASH group. The IMT of the aorta and carotid artery was increased in the NASH group compared with the control group. The IMT was reduced in NASH rats after treatment with PTX. Rats with NASH demonstrated higher AGE and RAGE protein levels in the liver and arteries compared with those of control rats. PTX treatment in NASH rats resulted in a decrease in AGE and RAGE protein levels in the liver and arteries compared with those in the NASH group.
CONCLUSION: Early atherosclerosis was observed in rats with NASH induced by a 16-week high-fat diet. High expression of AGE and RAGE in the livers and arteries of rats with NASH may contribute to the pathogenesis of NASH and early atherosclerosis. PTX showed protective effects on hepatic and arterial function, partially through inhibition of AGE and RAGE expression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20835270      PMCID: PMC4012909          DOI: 10.1038/aps.2010.110

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  43 in total

1.  Evidence that pioglitazone, metformin and pentoxifylline are inhibitors of glycation.

Authors:  S Rahbar; R Natarajan; K Yerneni; S Scott; N Gonzales; J L Nadler
Journal:  Clin Chim Acta       Date:  2000-11       Impact factor: 3.786

Review 2.  Receptor for age (RAGE) is a gene within the major histocompatibility class III region: implications for host response mechanisms in homeostasis and chronic disease.

Authors:  A M Schmidt; D M Stern
Journal:  Front Biosci       Date:  2001-10-01

Review 3.  The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses.

Authors:  A M Schmidt; S D Yan; S F Yan; D M Stern
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

4.  The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis.

Authors:  A J Wigg; I C Roberts-Thomson; R B Dymock; P J McCarthy; R H Grose; A G Cummins
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

5.  Pentoxifylline downregulates profibrogenic cytokines and procollagen I expression in rat secondary biliary fibrosis.

Authors:  C Raetsch; J D Jia; G Boigk; M Bauer; E G Hahn; E-O Riecken; D Schuppan
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

6.  Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial.

Authors:  E Akriviadis; R Botla; W Briggs; S Han; T Reynolds; O Shakil
Journal:  Gastroenterology       Date:  2000-12       Impact factor: 22.682

7.  Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation.

Authors:  H J Huttunen; J Kuja-Panula; G Sorci; A L Agneletti; R Donato; H Rauvala
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

Review 8.  The transcription factor NF-kappa B and the regulation of vascular cell function.

Authors:  R De Martin; M Hoeth; R Hofer-Warbinek; J A Schmid
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-11       Impact factor: 8.311

9.  Up-regulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts.

Authors:  H Fehrenbach; R Weiskirchen; M Kasper; A M Gressner
Journal:  Hepatology       Date:  2001-11       Impact factor: 17.425

10.  Increased hepatic UCP2 expression in rats with nonalcoholic steatohepatitis is associated with upregulation of Sp1 binding to its motif within the proximal promoter region.

Authors:  Ying Jiang; Hua Zhang; Ling-Yue Dong; Dan Wang; Wei An
Journal:  J Cell Biochem       Date:  2008-09-01       Impact factor: 4.429

View more
  10 in total

1.  Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis.

Authors:  Mohamed A Abdelmegeed; Atrayee Banerjee; Seong-Ho Yoo; Sehwan Jang; Frank J Gonzalez; Byoung-Joon Song
Journal:  J Hepatol       Date:  2012-06-02       Impact factor: 25.083

2.  Frontiers of vascular biology and disease research.

Authors:  Alex F Chen; Chao-shu Tang
Journal:  Acta Pharmacol Sin       Date:  2010-10       Impact factor: 6.150

3.  Increased hepatic apoptosis in high-fat diet-induced NASH in rats may be associated with downregulation of hepatic stimulator substance.

Authors:  Ying Jiang; Miaoyun Zhao; Wei An
Journal:  J Mol Med (Berl)       Date:  2011-08-04       Impact factor: 4.599

4.  Efficacy of MK615 for the treatment of patients with liver disorders.

Authors:  Atsushi Hokari; Tomohisa Ishikawa; Hisao Tajiri; Takahide Matsuda; Osamu Ishii; Nobuyuki Matsumoto; Chiaki Okuse; Hideaki Takahashi; Takeshi Kurihara; Ko-Ichi Kawahara; Ikuro Maruyama; Mikio Zeniya
Journal:  World J Gastroenterol       Date:  2012-08-21       Impact factor: 5.742

5.  Role of pentoxifylline in non-alcoholic fatty liver disease in high-fat diet-induced obesity in mice.

Authors:  Simone Coghetto Acedo; Cintia Rabelo E Paiva Caria; Érica Martins Ferreira Gotardo; José Aires Pereira; José Pedrazzoli; Marcelo Lima Ribeiro; Alessandra Gambero
Journal:  World J Hepatol       Date:  2015-10-28

6.  Correlation between Echo-Tracking Parameters and In Vitro Measurements of Arterial Contraction and Relaxation in Rats Fed a High-Cholesterol Diet.

Authors:  Yi Zhang; Wei-Wei Zhan; Yong-Jie Wu; Bo Zhao; Wu-Gang Zhou; Dong-Rui Chen; Wei Zhou; Zhen-Hua Liu; Wei-Min Jiang; Lin Zheng
Journal:  Med Sci Monit       Date:  2015-09-30

7.  Effects of RAGE Deletion on the Cardiac Transcriptome during Aging.

Authors:  Francesco Scavello; Luca Piacentini; Stefania Castiglione; Filippo Zeni; Federica Macrì; Manuel Casaburo; Maria Cristina Vinci; Gualtiero I Colombo; Angela Raucci
Journal:  Int J Mol Sci       Date:  2022-09-22       Impact factor: 6.208

8.  Zidovudine (AZT) and hepatic lipid accumulation: implication of inflammation, oxidative and endoplasmic reticulum stress mediators.

Authors:  Atrayee Banerjee; Mohamed A Abdelmegeed; Sehwan Jang; Byoung-Joon Song
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

9.  Pentoxifylline ameliorates non-alcoholic fatty liver disease in hyperglycaemic and dyslipidaemic mice by upregulating fatty acid β-oxidation.

Authors:  Jia-Hung Ye; Jung Chao; Ming-Ling Chang; Wen-Huang Peng; Hao-Yuan Cheng; Jiunn-Wang Liao; Li-Heng Pao
Journal:  Sci Rep       Date:  2016-09-09       Impact factor: 4.379

10.  Development of a Predictive Model to Induce Atherogenesis and Hepato-Renal Impairment in Female Rats.

Authors:  Lucas Pires Guarnier; Paulo Vitor Moreira Romão; Rhanany Alan Calloi Palozi; Aniely Oliveira Silva; Bethânia Rosa Lorençone; Aline Aparecida Macedo Marques; Ariany Carvalho Dos Santos; Roosevelt Isaias Carvalho Souza; Karine Delgado Souza; Emerson Luiz Botelho Lourenço; Arquimedes Gasparotto Junior
Journal:  Biomolecules       Date:  2019-10-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.